e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Advances in chronic obstructive pulmonary disease and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dexamethasone treatment for patients with COPD when they travel to high altitude
K. Bloch (Zurich, Switzerland)
Source:
International Congress 2019 – Advances in chronic obstructive pulmonary disease and asthma
Session:
Advances in chronic obstructive pulmonary disease and asthma
Session type:
Lunchtime session
Number:
4841
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Bloch (Zurich, Switzerland). Dexamethasone treatment for patients with COPD when they travel to high altitude. International Congress 2019 – Advances in chronic obstructive pulmonary disease and asthma
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006
Effects of acetazolamide on exercise performance in patients with COPD at high altitude. RCT.
Source: International Congress 2019 – Exploring exercise responses in respiratory diseases
Year: 2019
Six months azithromycin treatment in COPD patients with high risk of further exacerbations
Source: International Congress 2017 – Management of COPD
Year: 2017
The effect of high altitude climatic therapy on the course of bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 520s
Year: 2004
Different causes of COPD exacerbation: unable or not to use bronchodilator drugs and journey to high altitude
Source: Eur Respir J 2006; 28: Suppl. 50, 31s
Year: 2006
Blood eosinophil levels and exacerbations in a cohort of biomass and tobacco-related COPD patients at high altitude (2600 m)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020
The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002
Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Changes of lung‘s surfactant system in patients with COPD in conditions of high altitude
Source: Eur Respir J 2006; 28: Suppl. 50, 654s
Year: 2006
Effect of high dose oxygen on dyspnea and exercise tolerance in patients with COPD given LTOT
Source: Annual Congress 2007 - Effects of training in rehabilitation
Year: 2007
The effect of long-term treatment with erdosteine on moderate or severe COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 292s
Year: 2005
Effects of acetazolamide on sleep disordered breathing in patients with COPD staying at high altitude. RCT.
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019
Are inhaled corticosteroids increasing the “load” for some patients with COPD?
Source: Eur Respir J, 50 (4) 1701848; 10.1183/13993003.01848-2017
Year: 2017
Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive?
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013
Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
Chronic rhino-sinusitis in severe asthma improves at high altitude
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011
Impact of roflumilast treatment on the rate and duration of exacerbations and overall steroid load in patients with COPD
Source: Annual Congress 2011 - COPD management
Year: 2011
Effect of air travel and altitude in patients with respiratory conditions
Source: International Congress 2015 – ME8 Effect of air travel and altitude in patients with respiratory conditions
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept